Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Equity Income (2023 - 2025)

Bio-Techne has reported Equity Income over the past 3 years, most recently at $110000.0 for Q4 2025.

  • Quarterly results put Equity Income at $110000.0 for Q4 2025, up 139.13% from a year ago — trailing twelve months through Dec 2025 was $922000.0 (up 141.57% YoY), and the annual figure for FY2025 was $938000.0, up 113.71%.
  • Equity Income for Q4 2025 was $110000.0 at Bio-Techne, down from $294000.0 in the prior quarter.
  • Over the last five years, Equity Income for TECH hit a ceiling of $1.1 million in Q2 2025 and a floor of -$2.3 million in Q3 2023.
  • Median Equity Income over the past 3 years was -$271500.0 (2024), compared with a mean of -$550000.0.
  • Peak annual rise in Equity Income hit 224.24% in 2025, while the deepest fall reached 21.39% in 2025.
  • Bio-Techne's Equity Income stood at -$1.9 million in 2023, then soared by 102.4% to $46000.0 in 2024, then skyrocketed by 139.13% to $110000.0 in 2025.
  • The last three reported values for Equity Income were $110000.0 (Q4 2025), $294000.0 (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.